Medical

Invitae

$55.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.07 (+1.92%) Today
-$1.23 (-2.16%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Invitae and other stocks, options, and ETFs commission-free!

About NVTA

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA. The listed name for NVTA is Invitae Corporation.

CEO
Sean Emerson George
Employees
1,300
Headquarters
San Francisco, California
Founded
2010
Market Cap
10.06B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.09M
High Today
$60.25
Low Today
$56.77
Open Price
$56.92
Volume
4.81M
52 Week High
$61.59
52 Week Low
$7.42

Collections

NVTA Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 17, After Hours

You May Also Like

SGDM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure